We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
(+7.6%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$218M |
| 2 |
Parker-Hannifin
PH
|
+$155M |
| 3 |
Illumina
ILMN
|
+$80.7M |
| 4 |
Walt Disney
DIS
|
+$74.2M |
| 5 |
AZEK
The AZEK Co
AZEK
|
+$56.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$819M |
| 2 |
Meta Platforms (Facebook)
META
|
+$338M |
| 3 |
Microsoft
MSFT
|
+$131M |
| 4 |
Amazon
AMZN
|
+$106M |
| 5 |
Salesforce
CRM
|
+$93.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.29% |
| 2 | Communication Services | 16.35% |
| 3 | Consumer Discretionary | 16.22% |
| 4 | Healthcare | 12.62% |
| 5 | Financials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Maravai LifeSciences
MRVI
$919M
| $4K | ﹤0.01% |
354
-1,266
| -78% | -$17.1K |
|
852
MGIC Investment
MTG
$6.25B
| $4K | ﹤0.01% |
250
-1,560
| -86% | -$23.1K |
|
853
NRG Energy
NRG
$24.8B
| $4K | ﹤0.01% |
105
-250
| -70% | -$8.51K |
|
854
NetApp
NTAP
$37.2B
| $4K | ﹤0.01% |
48
-142
| -75% | -$9.59K |
|
855
OneMain Financial
OMF
$7.47B
| $4K | ﹤0.01% |
91
-917
| -91% | -$35.8K |
|
856
Penske Automotive Group
PAG
$14.2B
| $4K | ﹤0.01% |
24
-112
| -82% | -$16.2K |
|
857
Ultragenyx Pharmaceutical
RARE
$2.55B
| $4K | ﹤0.01% |
+85
| New | +$3.94K |
|
858
Sunrun
RUN
$2.46B
| $4K | ﹤0.01% |
251
-183
| -42% | -$3.4K |
|
859
Toast
TOST
$19.9B
| $4K | ﹤0.01% |
195
-233
| -54% | -$4.65K |
|
860
Texas Pacific Land
TPL
$23.5B
| $4K | ﹤0.01% |
27
+9
| +50% | +$1.44K |
|
861
Tapestry
TPR
$32.8B
| $4K | ﹤0.01% |
+82
| New | +$3.41K |
|
862
United Airlines
UAL
$42.1B
| $4K | ﹤0.01% |
+77
| New | +$3.64K |
|
|
VSXY
863
Victoria's Secret
VSXY
$7.83B
| $4K | ﹤0.01% |
+210
| New | +$5.29K |
|
864
Zscaler
ZS
$27.3B
| $4K | ﹤0.01% |
28
-39
| -58% | -$4.76K |
|
|
SYNH
865
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4K | ﹤0.01% |
93
-228
| -71% | -$9.22K |
|
|
PDCE
866
DELISTED
PDC Energy, Inc.
PDCE
| $4K | ﹤0.01% |
53
-355
| -87% | -$24K |
|
867
Albertsons Companies
ACI
$5.83B
| $3K | ﹤0.01% |
160
-378
| -70% | -$7.87K |
|
868
Biogen
BIIB
$30.7B
| $3K | ﹤0.01% |
11
-9
| -45% | -$2.68K |
|
|
CMA
869
DELISTED
Comerica
CMA
| $3K | ﹤0.01% |
+75
| New | +$3.03K |
|
870
Coinbase
COIN
$40.5B
| $3K | ﹤0.01% |
+46
| New | +$2.74K |
|
871
Capri Holdings
CPRI
$1.74B
| $3K | ﹤0.01% |
+75
| New | +$2.98K |
|
872
HF Sinclair
DINO
$14.5B
| $3K | ﹤0.01% |
67
-244
| -78% | -$10.6K |
|
873
Dick's Sporting Goods
DKS
$18.7B
| $3K | ﹤0.01% |
23
-4
| -15% | -$547 |
|
874
Erie Indemnity
ERIE
$13.2B
| $3K | ﹤0.01% |
15
| – | – |
|
875
First Citizens BancShares
FCNCA
$25.3B
| $3K | ﹤0.01% |
2
-8
| -80% | -$9.25K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2023 Portfolio in Review
As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.
- Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
- Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
- Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
- Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
- Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
- Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
- Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.